News

In a bid to combat corruption and promote accountability in Liberia’s forestry sector, Integrity Watch Liberia has concluded a two-day capacity-building workshop aimed at training over 20 ...
VAMBO TOWNSHIP – Eleven townspeople have been elected to a community forest leadership in Grand Bassa County, calming months of tension over their towns’ alleged misrepresentation. By Emmanuel Sherman ...
Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific advisers crossed the line for her.
Reaffirming India''s pivotal role in the global pharmaceutical industry, Minister of State for Health and Family Welfare, Anupriya Patel on Monday pointed out that 70 percent of the World Health ...
The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. The Food and Drug Administration ...
Four Democrat-led states ask FDA to remove abortion pill restrictions The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on ...
The Liberia National Rubber Pricing Committee set farmers’ pay at $574.06 per ton of cup lumps or slabs on Tuesday, 15.3% higher than the rate Firestone currently pays.
The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency from unveiling a new generative AI tool a month ahead of schedule.
The FDA launched a generative artificial intelligence (AI) tool, dubbed Elsa, designed to help employees such as scientific reviewers and investigators work more efficiently, the agency announced ...
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help agency staff in drug clinical evaluations and reviews. FDA Artificial ...
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots.
The FDA and Stealth look set to relitigate the debate, with the biotech planning to file for approval once again. Stealth has laid off 30% of its staff to free up funds for the resubmission. The ...